BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishii H, Zanesi N, Vecchione A, Trapasso F, Yendamuri S, Sarti M, Baffa R, During MJ, Huebner K, Fong LY. Regression of upper gastric cancer in mice by FHIT gene delivery. FASEB J. 2003;17:1768-1770. [PMID: 12958204 DOI: 10.1096/fj.03-0241fje] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Druck T, Cheung DG, Park D, Trapasso F, Pichiorri F, Gaspari M, Palumbo T, Aqeilan RI, Gaudio E, Okumura H, Iuliano R, Raso C, Green K, Huebner K, Croce CM. Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells. Cell Death Dis 2019;10:147. [PMID: 30770797 DOI: 10.1038/s41419-019-1414-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
2 Silveira Zavalhia L, Weber Medeiros A, Oliveira Silva A, Vial Roehe A. Do FHIT gene alterations play a role in human solid tumors? Asia-Pac J Clin Oncol 2018;14:e214-23. [DOI: 10.1111/ajco.12868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gaudio E, Paduano F, Croce CM, Trapasso F. The Fhit protein: an opportunity to overcome chemoresistance. Aging (Albany NY) 2016;8:3147-50. [PMID: 27852977 DOI: 10.18632/aging.101123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
4 Boylston J, Brenner C. FHIT. Encyclopedia of Signaling Molecules 2018. [DOI: 10.1007/978-3-319-67199-4_68] [Reference Citation Analysis]
5 Gaudio E, Paduano F, Ngankeu A, Ortuso F, Lovat F, Pinton S, D'Agostino S, Zanesi N, Aqeilan RI, Campiglia P, Novellino E, Alcaro S, Croce CM, Trapasso F. A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells. Oncotarget 2016;7:29927-36. [PMID: 27166255 DOI: 10.18632/oncotarget.9179] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kiss DL, Waters CE, Ouda IM, Saldivar JC, Karras JR, Amin ZA, Mahrous S, Druck T, Bundschuh RA, Schoenberg DR, Huebner K. Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression. Biochim Biophys Acta Gene Regul Mech 2017;1860:374-82. [PMID: 28093273 DOI: 10.1016/j.bbagrm.2017.01.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
7 Karras JR, Paisie CA, Huebner K. Replicative Stress and the FHIT Gene: Roles in Tumor Suppression, Genome Stability and Prevention of Carcinogenesis. Cancers (Basel) 2014;6:1208-19. [PMID: 24901304 DOI: 10.3390/cancers6021208] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
8 Miuma S, Saldivar JC, Karras JR, Waters CE, Paisie CA, Wang Y, Jin V, Sun J, Druck T, Zhang J, Huebner K. Fhit deficiency-induced global genome instability promotes mutation and clonal expansion. PLoS One 2013;8:e80730. [PMID: 24244712 DOI: 10.1371/journal.pone.0080730] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
9 Yu GR, Qin WW, Li JP, Hua W, Meng YL, Chen R, Yan B, Wang L, Zhang X, Jia LT, Zhao J, Zhang R, Yang AG. HIV-TAT-fused FHIT protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells. Biosci Rep 2012;32:271-9. [PMID: 21679157 DOI: 10.1042/BSR20110033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
10 Sun J, Liu J, Pan X, Quimby D, Zanesi N, Druck T, Pfeifer GP, Croce CM, Fong LY, Huebner K. Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains. Carcinogenesis 2011;32:351-8. [PMID: 21097531 DOI: 10.1093/carcin/bgq251] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
11 Song X, Tian Z, Wang S, Peng Z, Feng J. Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line. Cancer Invest 2010;28:1019-23. [PMID: 20690795 DOI: 10.3109/07357900902849608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
12 Stec-Michalska K, Peczek L, Michalski B, Wisniewska-Jarosinska M, Krakowiak A, Nawrot B. Helicobacter pylori infection and family history of gastric cancer decrease expression of FHIT tumor suppressor gene in gastric mucosa of dyspeptic patients. Helicobacter 2009;14:126-34. [PMID: 19751438 DOI: 10.1111/j.1523-5378.2009.00715.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
13 Mirandola P, Gobbi G, Sponzilli I, Malinverno C, Cavazzoni A, Alfieri R, Petronini PG, Vitale M. TRAIL-induced apoptosis of FHIT-negative lung cancer cells is inhibited by FHIT re-expression. J Cell Physiol 2009;220:492-8. [DOI: 10.1002/jcp.21801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
14 Ferens B, Kawiak A, Banecki B, Bielawski KP, Zawacka-pankau J. Aberration of the enzymatic activity of Fhit tumor suppressor protein enhances cancer cell death upon photodynamic therapy similarly to that driven by wild-type Fhit. Cancer Letters 2009;280:101-9. [DOI: 10.1016/j.canlet.2009.02.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
15 Karam JA, Shariat SF, Hsieh J, Knowles MA. Genomics: a preview of genomic medicine. BJU International 2008;102:1221-7. [DOI: 10.1111/j.1464-410x.2008.07963.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
16 Wang T, Frezza EE, Ma R, Hu S, Liu C, Zhang G, Wachtel MS, Lü X, Feng J, Lü C. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities: . Chinese Medical Journal 2008;121:1969-74. [DOI: 10.1097/00029330-200810020-00004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
17 Nishi J, Fumoto S, Ishii H, Kodama Y, Nakashima M, Sasaki H, Nakamura J, Nishida K. Improved stomach selectivity of gene expression following microinstillation of plasmid DNA onto the gastric serosal surface in mice. European Journal of Pharmaceutics and Biopharmaceutics 2008;69:633-9. [DOI: 10.1016/j.ejpb.2007.12.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
18 Trapasso F, Pichiorri F, Gaspari M, Palumbo T, Aqeilan RI, Gaudio E, Okumura H, Iuliano R, Di Leva G, Fabbri M, Birk DE, Raso C, Green-Church K, Spagnoli LG, Venuta S, Huebner K, Croce CM. Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells. J Biol Chem 2008;283:13736-44. [PMID: 18319262 DOI: 10.1074/jbc.M709062200] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 3.7] [Reference Citation Analysis]
19 Yutori H, Semba S, Komori T, Yokozaki H. Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cells. Cancer Science 2008;99:524-30. [DOI: 10.1111/j.1349-7006.2007.00707.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
20 Khalighinejad N, Hariri H, Behnamfar O, Yousefi A, Momeni A. Adenoviral gene therapy in gastric cancer: A review. World J Gastroenterol 2008; 14(2): 180-184 [PMID: 18186552 DOI: 10.3748/wjg.14.180] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
21 McCorkell KA, Mancini R, Siprashvili Z, Barnoski BL, Iliopoulos D, Siracusa LD, Zanesi N, Croce CM, Fong LY, Druck T, Huebner K. Influence of a nonfragile FHIT transgene on murine tumor susceptibility. Cytogenet Genome Res 2007;118:196-203. [PMID: 18000371 DOI: 10.1159/000108301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Cantor JP, Iliopoulos D, Rao AS, Druck T, Semba S, Han SY, McCorkell KA, Lakshman TV, Collins JE, Wachsberger P, Friedberg JS, Huebner K. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. Int J Cancer 2007;120:24-31. [PMID: 17019711 DOI: 10.1002/ijc.22073] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 3.1] [Reference Citation Analysis]
23 Andriani F, Perego P, Carenini N, Sozzi G, Roz L. Increased sensitivity to cisplatin in non-small cell lung cancer cell lines after FHIT gene transfer. Neoplasia. 2006;8:9-17. [PMID: 16533421 DOI: 10.1593/neo.05517] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
24 Letessier A, Garrido-Urbani S, Ginestier C, Fournier G, Esterni B, Monville F, Adélaïde J, Geneix J, Xerri L, Dubreuil P. Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene. 2007;26:298-307. [PMID: 16819513 DOI: 10.1038/sj.onc.1209772] [Cited by in Crossref: 62] [Cited by in F6Publishing: 74] [Article Influence: 3.6] [Reference Citation Analysis]
25 Sutter AP, Fechner H. Gene therapy for gastric cancer: Is it promising? World J Gastroenterol 2006; 12(3): 380-387 [PMID: 16489636 DOI: 10.3748/wjg.v12.i3.380] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
26 Huang K, Arabshahi A, Frey PA. pH-Dependence in the Hydrolytic Action of the Human Fragile Histidine Triad. Eur J Org Chem 2005;2005:5198-206. [DOI: 10.1002/ejoc.200500499] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
27 Bragantini E, Barbi S, Beghelli S, Moore PS, de Manzoni G, Roviello F, Tomezzoli A, Vindigni C, Baffa R, Scarpa A. Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker. J Cancer Res Clin Oncol. 2006;132:45-50. [PMID: 16217683 DOI: 10.1007/s00432-005-0045-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
28 Hussain A, Gutierrez MI, Timson G, Siraj AK, Deambrogi C, Al-Rasheed M, Gaidano G, Magrath I, Bhatia K. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation. Genes Chromosomes Cancer. 2004;41:321-329. [PMID: 15384174 DOI: 10.1002/gcc.20099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
29 Zanesi N, Pekarsky Y, Croce CM. A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention. Mutat Res 2005;591:103-9. [PMID: 16085127 DOI: 10.1016/j.mrfmmm.2005.05.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
30 Zhao XH, Gu SZ, Tian HG, Quan P, Pan BR. Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue. World J Gastroenterol 2005; 11(25): 3846-3849 [PMID: 15991280 DOI: 10.3748/wjg.v11.i25.3846] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
31 Garrison PN, Robinson AK, Pekarsky Y, Croce CM, Barnes LD. Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphorylated forms. Biochemistry 2005;44:6286-92. [PMID: 15835917 DOI: 10.1021/bi047670s] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
32 Liu P, You SH, Zhang XY, Zhang DF, Ding XJ. Heterozygosity loss of fragile histidine triad gene in gastric cancer and precancerous lesions. Shijie Huaren Xiaohua Zazhi 2005; 13(10): 1190-1193 [DOI: 10.11569/wcjd.v13.i10.1190] [Reference Citation Analysis]
33 Stec-Michalska K, Antoszczyk S, Klupinska G, Nawrot B. Loss of FHIT expression in gastric mucosa of patients with family histories of gastric cancer and Helicobacter pylori infection. World J Gastroenterol 2005; 11(1): 17-21 [PMID: 15609389 DOI: 10.3748/wjg.v11.i1.17] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
34 Ottey M, Han SY, Druck T, Barnoski BL, McCorkell KA, Croce CM, Raventos-Suarez C, Fairchild CR, Wang Y, Huebner K. Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant. Br J Cancer 2004;91:1669-77. [PMID: 15494723 DOI: 10.1038/sj.bjc.6602058] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
35 Lambert R. Cancer : La triade de l’histidine fragile. Acta Endosc 2004;34:262-262. [DOI: 10.1007/bf03009022] [Reference Citation Analysis]
36 Lemoine NR, McNeish IA. Gene transfer: Bax to the future for cancer therapy. Gut 2004;53:478-9. [PMID: 15016738 DOI: 10.1136/gut.2003.030312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
37 Ishii H, Ozawa K, Furukawa Y. Alteration of the fragile histidine triad gene early in carcinogenesis: an update. J Exp Ther Oncol. 2003;3:291-296. [PMID: 14678517 DOI: 10.1111/j.1533-869x.2003.01101.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
38 Matsuyama A, Shiraishi T, Trapasso F, Kuroki T, Alder H, Mori M, Huebner K, Croce CM. Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic. Proc Natl Acad Sci USA. 2003;100:14988-14993. [PMID: 14630947 DOI: 10.1073/pnas.2336256100] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]